CRO Solutions, Inc. has launched VxP Pharma, Inc. as a wholly owned subsidiary comprised of the combined services of its independently owned and operated “niche” CROs. VxP Pharma will offer pharma development services, as well as technical support, for the development and production of drugs, diagnostics, and drug/device combination products, from discovery through Phase IIb. The majority of VxP Pharma’s Labs are located in the U.S., although the group also has facilities in E...